Self-Replicating RNAs Drive Protective Anti-tumor T Cell Responses to Neoantigen Vaccine Targets in a Combinatorial Approach by Riley Nolan | Jun 8, 2021
Ancer-designed CT26 RNA Replicon Neo-epitope Vaccine Induces Multi-functional CD4 and CD8 T Cell Responses by Annie De Groot | Oct 5, 2018EpiVax_ISV2018_CT26_01Oct18_50Wx36H
